.
BNGO financial statements
* Numbers in thousands
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
Capitalization * |
40 824 | 37 359 | 1 469 009 | 236 637 |
EV * |
33 330 | 40 133 | 1 446 886 | 1 446 886 |
Stock price $ |
4.06 | 1.09 | 11.05 | 1.78 |
Number of shares * |
10 055 | 34 274 | 132 942 | 132 942 |
EPS |
-1,84 | -0,87 | -0,31 | -0,31 |
Revenue * |
12 001 | 10 130 | 8 503 | 8 503 |
Net income * |
-18 496 | -29 815 | -41 106 | -41 106 |
Operating profit * |
-20 415 | -25 875 | -38 551 | -38 551 |
Total liabilities * |
14 665 | 26 594 | 25 367 | 25 367 |
Net debt * |
-7 493 | 2 774 | -2 038 | -2 038 |
Total assets * |
24 802 | 30 208 | 60 450 | 60 450 |
Equity * |
10 137 | 3 614 | 35 082 | 35 082 |
Cash and investments * |
16 523 | 17 311 | 38 449 | 38 449 |
Over the past 10 years, the maximum capitalization of Bionano Genomics, Inc. is 1 469 009, the minimum is 37 359. Maximum net income 0, Minimum net income -41 106. The maximum price of BNGO shares is 11.05, the minimum price is 1.09.
.
BNGO valuation
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
P/E |
-2,21 | -1,25 | -35,74 | -5,76 |
P/B |
4,03 | 10,34 | 41,87 | 6,75 |
P/S |
3,40 | 3,69 | 172,76 | 27,83 |
E/P |
-45% | -80% | -3% | -17% |
P/FCF |
-2,01 | -1,26 | -38,34 | -6,18 |
.
BNGO profitability
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
ROE |
-182% | -825% | -117% | |
ROA |
-75% | -99% | -79% | |
ROIC |
-101% | -674% | -75% |